Design and Validation of a Process Based on Cationic Niosomes for Gene Delivery into Novel Urine-Derived Mesenchymal Stem Cells.

MLA

Vado, Yerai, et al. “Design and Validation of a Process Based on Cationic Niosomes for Gene Delivery into Novel Urine-Derived Mesenchymal Stem Cells.” Pharmaceutics, vol. 13, no. 5, May 2021. EBSCOhost, https://doi.org/10.3390/pharmaceutics13050696.

APA

Vado, Y., Puras, G., Rosique, M., Martin, C., Pedraz, J. L., Jebari-Benslaiman, S., de Pancorbo, M. M., Zarate, J., & Perez de Nanclares, G. (2021). Design and Validation of a Process Based on Cationic Niosomes for Gene Delivery into Novel Urine-Derived Mesenchymal Stem Cells. Pharmaceutics, 13(5). https://doi.org/10.3390/pharmaceutics13050696

Chicago

Vado, Yerai, Gustavo Puras, Melania Rosique, Cesar Martin, Jose Luis Pedraz, Shifa Jebari-Benslaiman, Marian M de Pancorbo, Jon Zarate, and Guiomar Perez de Nanclares. 2021. “Design and Validation of a Process Based on Cationic Niosomes for Gene Delivery into Novel Urine-Derived Mesenchymal Stem Cells.” Pharmaceutics 13 (5). doi:10.3390/pharmaceutics13050696.